Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy

Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Lee, 1993, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, 75, 843, 10.1016/0092-8674(93)90529-Y Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 403, 901, 10.1038/35002607 Cheng, 2009 Turchinovich, 2012, Extracellular miRNAs: the mystery of their origin and function, Trends Biochem. Sci., 37, 460, 10.1016/j.tibs.2012.08.003 Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res., 18, 997, 10.1038/cr.2008.282 Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U. S. A., 105, 10513, 10.1073/pnas.0804549105 Shen, 2013, MicroRNAs as potential biomarkers in human solid tumors, Cancer Lett., 329, 125, 10.1016/j.canlet.2012.11.001 Lee, 2003, The nuclear RNase III Drosha initiates microRNA processing, Nature, 425, 415, 10.1038/nature01957 Filippov, 2000, A novel type of RNase III family proteins in eukaryotes, Gene, 245, 213, 10.1016/S0378-1119(99)00571-5 Gregory, 2004, The Microprocessor complex mediates the genesis of microRNAs, Nature, 432, 235, 10.1038/nature03120 Denli, 2004, Processing of primary microRNAs by the Microprocessor complex, Nature, 432, 231, 10.1038/nature03049 Lund, 2004, Nuclear export of microRNA precursors, Science, 303, 95, 10.1126/science.1090599 Bohnsack, 2004, Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs, RNA, 10, 185, 10.1261/rna.5167604 Yi, 2003, Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs, Genes Dev., 17, 3011, 10.1101/gad.1158803 Zeng, 2004, Structural requirements for pre-microRNA binding and nuclear export by Exportin 5, Nucleic Acids Res., 32, 4776, 10.1093/nar/gkh824 Bernstein, 2001, Role for a bidentate ribonuclease in the initiation step of RNA interference, Nature, 409, 363, 10.1038/35053110 Chendrimada, 2005, TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing, Nature, 436, 740, 10.1038/nature03868 Lau, 2013, The molecular architecture of human Dicer, Nat. Struct. Mol. Biol., 19, 436, 10.1038/nsmb.2268 Pasquinelli, 2012, MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship, Nat. Rev. Genet., 13, 271, 10.1038/nrg3162 Berezikov, 2007, Mammalian mirtron genes, Mol. Cell, 28, 328, 10.1016/j.molcel.2007.09.028 Okamura, 2007, The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila, Cell, 130, 89, 10.1016/j.cell.2007.06.028 Ruby, 2007, Intronic microRNA precursors that bypass Drosha processing, Nature, 448, 83, 10.1038/nature05983 Babiarz, 2008, Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs, Genes Dev., 22, 2773, 10.1101/gad.1705308 Bogerd, 2010, A mammalian herpesvirus uses noncanonical expression and processing mechanisms to generate viral microRNAs, Mol. Cell, 37, 135, 10.1016/j.molcel.2009.12.016 Cazalla, 2011, A primate herpesvirus uses the integrator complex to generate viral microRNAs, Mol. Cell, 43, 982, 10.1016/j.molcel.2011.07.025 Cheloufi, 2010, A dicer-independent miRNA biogenesis pathway that requires Ago catalysis, Nature, 465, 584, 10.1038/nature09092 Cifuentes, 2010, A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity, Science, 328, 1694, 10.1126/science.1190809 Yang, 2010, Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis, Proc. Natl. Acad. Sci. U. S. A., 107, 15163, 10.1073/pnas.1006432107 Maute, 2013, tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma, Proc. Natl. Acad. Sci. U. S. A., 110, 1404, 10.1073/pnas.1206761110 Kumar, 2009, Dicer1 functions as a haploinsufficient tumor suppressor, Genes Dev., 23, 2700, 10.1101/gad.1848209 Sand, 2012, Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer, Mol. Carcinog., 51, 916, 10.1002/mc.20861 Guo, 2013, Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion, Pharm. Res., 10.1007/s11095-013-1219-9 Papachristou, 2011, Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas, Virchows Arch., 459, 431, 10.1007/s00428-011-1119-5 Khoshnaw, 2012, Loss of Dicer expression is associated with breast cancer progression and recurrence, Breast Cancer Res. Treat., 135, 403, 10.1007/s10549-012-2169-3 Jafarnejad, 2013, Expression of the RNase III enzyme DROSHA is reduced during progression of human cutaneous melanoma, Mod. Pathol., 26, 902, 10.1038/modpathol.2012.225 Melo, 2014, Disruption of microRNA nuclear transport in human cancer, Semin. Cancer Biol., 27, 46, 10.1016/j.semcancer.2014.02.012 Kawai, 2012, BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex, J. Cell Biol., 197, 201, 10.1083/jcb.201110008 Suzuki, 2009, Modulation of microRNA processing by p53, Nature, 460, 529, 10.1038/nature08199 Jiang, 2013, Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women, Int. J. Cancer, 133, 2216, 10.1002/ijc.28237 Horikawa, 2008, Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma, Clin. Cancer Res., 14, 7956, 10.1158/1078-0432.CCR-08-1199 Liu, 2012, Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case–control study of the Chinese Han population, DNA Cell Biol., 31, 1296, 10.1089/dna.2011.1600 Liu, 2013, Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma, Mol. Carcinog., 52, E148, 10.1002/mc.22062 Liu, 2014, Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma, PLoS One, 9, e92791, 10.1371/journal.pone.0092791 Chim, 2008, Detection and characterization of placental microRNAs in maternal plasma, Clin. Chem., 54, 482, 10.1373/clinchem.2007.097972 Lawrie, 2008, Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma, Br. J. Haematol., 141, 672, 10.1111/j.1365-2141.2008.07077.x Park, 2009, Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection, Clin. Cancer Res., 15, 5473, 10.1158/1078-0432.CCR-09-0736 Hanke, 2010, A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer, Urol. Oncol., 28, 655, 10.1016/j.urolonc.2009.01.027 Kosaka, 2010, microRNA as a new immune-regulatory agent in breast milk, Silence, 1, 7, 10.1186/1758-907X-1-7 Weber, 2010, The microRNA spectrum in 12 body fluids, Clin. Chem., 56, 1733, 10.1373/clinchem.2010.147405 Pigati, 2010, Selective release of microRNA species from normal and malignant mammary epithelial cells, PLoS One, 5, e13515, 10.1371/journal.pone.0013515 Jaiswal, 2012, Microparticle conferred microRNA profiles—implications in the transfer and dominance of cancer traits, Mol. Cancer, 11, 37, 10.1186/1476-4598-11-37 Kosaka, 2010, Secretory mechanisms and intercellular transfer of microRNAs in living cells, J. Biol. Chem., 285, 17442, 10.1074/jbc.M110.107821 Yang, 2011, Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells, Mol. Cancer, 10, 117, 10.1186/1476-4598-10-117 Ji, 2009, Plasma miR-208 as a biomarker of myocardial injury, Clin. Chem., 55, 1944, 10.1373/clinchem.2009.125310 Wang, 2009, Circulating microRNAs, potential biomarkers for drug-induced liver injury, Proc. Natl. Acad. Sci. U. S. A., 106, 4402, 10.1073/pnas.0813371106 Ramachandran, 2013, Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury, Clin. Chem., 59, 1742, 10.1373/clinchem.2013.210245 Zernecke, 2009, Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection, Sci. Signal., 2, ra81, 10.1126/scisignal.2000610 Majno, 1995, Apoptosis, oncosis, and necrosis. An overview of cell death, Am. J. Pathol., 146, 3 Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat. Cell Biol., 13, 423, 10.1038/ncb2210 Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc. Natl. Acad. Sci. U. S. A., 108, 5003, 10.1073/pnas.1019055108 Wang, 2010, Export of microRNAs and microRNA-protective protein by mammalian cells, Nucleic Acids Res., 38, 7248, 10.1093/nar/gkq601 Cortez, 2009, MicroRNAs in body fluids—the mix of hormones and biomarkers, Nat. Rev. Clin. Oncol., 8, 467, 10.1038/nrclinonc.2011.76 Aucher, 2013, MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation, J. Immunol., 191, 6250, 10.4049/jimmunol.1301728 Lim, 2011, Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells, Cancer Res., 71, 1550, 10.1158/0008-5472.CAN-10-2372 Hu, 2012, Exosomal miRNAs: biological properties and therapeutic potential, Front. Genet., 3, 56, 10.3389/fgene.2012.00056 Liang, 2013, New roles for microRNAs in cross-species communication, RNA Biol., 10, 367, 10.4161/rna.23663 LaMonte, 2012, Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance, Cell Host Microbe, 12, 187, 10.1016/j.chom.2012.06.007 Cheng, 2013, Deep sequencing-based identification of pathogen-specific microRNAs in the plasma of rabbits infected with Schistosoma japonicum, Parasitology, 140, 1751, 10.1017/S0031182013000917 Kogure, 2011, Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth, Hepatology, 54, 1237, 10.1002/hep.24504 Li, 2013, Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis, J. Biol. Chem., 288, 23586, 10.1074/jbc.M113.489302 Zhang, 2010, Secreted monocytic miR-150 enhances targeted endothelial cell migration, Mol. Cell, 39, 133, 10.1016/j.molcel.2010.06.010 Zhuang, 2012, Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK–STAT pathway, EMBO J., 31, 3513, 10.1038/emboj.2012.183 Skog, 2008, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat. Cell Biol., 10, 1470, 10.1038/ncb1800 Kosaka, 2013, Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis, J. Biol. Chem., 288, 10849, 10.1074/jbc.M112.446831 Zhou, 2014, Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis, Cancer Cell, 25, 501, 10.1016/j.ccr.2014.03.007 Lee, 2013, Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells, PLoS One, 8, e84256, 10.1371/journal.pone.0084256 Bronisz, 2014, Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1, Cancer Res., 74, 738, 10.1158/0008-5472.CAN-13-2650 Tadokoro, 2013, Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells, J. Biol. Chem., 288, 34343, 10.1074/jbc.M113.480822 Pan, 2013, MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling, Int. J. Immunopathol. Pharmacol., 25, 871, 10.1177/039463201202500405 Zhang, 2013, Secreted monocytic miR-150 enhances targeted endothelial cell migration, Mol. Cell, 39, 133, 10.1016/j.molcel.2010.06.010 Lee, 2009, MicroRNAs in cancer, Annu. Rev. Pathol., 4, 199, 10.1146/annurev.pathol.4.110807.092222 Henschke, 2006, Survival of patients with stage I lung cancer detected on CT screening, N. Engl. J. Med., 355, 1763, 10.1056/NEJMoa060476 Foss, 2011, miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer, J. Thorac. Oncol., 6, 482, 10.1097/JTO.0b013e318208c785 Zheng, 2011, Plasma microRNAs as novel biomarkers for early detection of lung cancer, Int. J. Clin. Exp. Pathol., 4, 575 Shen, 2011, Plasma microRNAs as potential biomarkers for non-small-cell lung cancer, Lab. Invest., 91, 579, 10.1038/labinvest.2010.194 Chen, 2012, Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis, Int. J. Cancer, 130, 1620, 10.1002/ijc.26177 Bianchi, 2011, A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer, EMBO Mol. Med., 3, 495, 10.1002/emmm.201100154 Bianchi, 2012, Circulating microRNAs: next-generation biomarkers for early lung cancer detection, Ecancermedicalscience, 6, 246 Silva, 2011, Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival, Eur. Respir. J., 37, 617, 10.1183/09031936.00029610 Hu, 2010, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer, J. Clin. Oncol., 28, 1721, 10.1200/JCO.2009.24.9342 Cui, 2013, Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy, Acta Pharmacol. Sin., 34, 309, 10.1038/aps.2012.125 Kaduthanam, 2013, Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients, Lung Cancer, 80, 223, 10.1016/j.lungcan.2013.01.013 Franchina, 2014, Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer, J. Cell. Physiol., 229, 97 Wei, 2011, Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer, Chin. J. Cancer, 30, 407, 10.5732/cjc.010.10522 Heegaard, 2012, Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer, Int. J. Cancer, 130, 1378, 10.1002/ijc.26153 Abd-El-Fattah, 2013, Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia, Cell Biochem. Biophys., 67, 875, 10.1007/s12013-013-9575-y Yuxia, 2012, Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis, J. Cancer Res. Clin. Oncol., 138, 2045, 10.1007/s00432-012-1285-0 Le, 2012, Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients, Med. Oncol., 29, 3190, 10.1007/s12032-012-0303-z Wang, 2012, The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors, J. Cancer Res. Clin. Oncol., 138, 1659, 10.1007/s00432-012-1244-9 Han, 2013, Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion, Int. J. Cancer, 133, 645, 10.1002/ijc.28054 Aushev, 2013, Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma, PLoS One, 8, e78649, 10.1371/journal.pone.0078649 Zhu, 2009, Circulating microRNAs in breast cancer and healthy subjects, BMC Res. Notes, 2, 89, 10.1186/1756-0500-2-89 Roth, 2010, Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer, Breast Cancer Res., 12, R90, 10.1186/bcr2766 Sun, 2012, Serum microRNA-155 as a potential biomarker to track disease in breast cancer, PLoS One, 7, e47003, 10.1371/journal.pone.0047003 Mar-Aguilar, 2013, Serum circulating microRNA profiling for identification of potential breast cancer biomarkers, Dis. Markers, 34, 163, 10.1155/2013/259454 Ng, 2013, Circulating microRNAs as specific biomarkers for breast cancer detection, PLoS One, 8, e53141, 10.1371/journal.pone.0053141 Heneghan, 2010, Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease, Oncologist, 15, 673, 10.1634/theoncologist.2010-0103 Asaga, 2011, Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer, Clin. Chem., 57, 84, 10.1373/clinchem.2010.151845 Chan, 2013, Identification of circulating microRNA signatures for breast cancer detection, Clin. Cancer Res., 19, 4477, 10.1158/1078-0432.CCR-12-3401 Cuk, 2013, Circulating microRNAs in plasma as early detection markers for breast cancer, Int. J. Cancer, 132, 1602, 10.1002/ijc.27799 Wu, 2012, De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer, J. Transl. Med., 10, 42, 10.1186/1479-5876-10-42 Eichelser, 2013, Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression, Clin. Chem., 59, 1489, 10.1373/clinchem.2013.205161 Schwarzenbach, 2012, Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients, Breast Cancer Res. Treat., 134, 933, 10.1007/s10549-012-1988-6 Chen, 2013, The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers, Tumour Biol., 34, 455, 10.1007/s13277-012-0570-5 Wang, 2012, Circulating MiR-125b as a marker predicting chemoresistance in breast cancer, PLoS One, 7, e34210, 10.1371/journal.pone.0034210 Jung, 2012, Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients, Cancer, 118, 2603, 10.1002/cncr.26565 McDermott, 2014, Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer, PLoS One, 9, e87032, 10.1371/journal.pone.0087032 Heneghan, 2010, Circulating microRNAs as novel minimally invasive biomarkers for breast cancer, Ann. Surg., 251, 499, 10.1097/SLA.0b013e3181cc939f Cookson, 2012, Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours, Cell Oncol. (Dordr.), 35, 301, 10.1007/s13402-012-0089-1 Schrauder, 2012, Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection, PLoS One, 7, e29770, 10.1371/journal.pone.0029770 van Schooneveld, 2012, Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers, Breast Cancer Res., 14, R34, 10.1186/bcr3127 Wang, 2013, Higher expression of circulating miR-182 as a novel biomarker for breast cancer, Oncol. Lett., 6, 1681, 10.3892/ol.2013.1593 Zeng, 2013, Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer, Med. Oncol., 30, 477, 10.1007/s12032-013-0477-z Si, 2013, Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer, J. Cancer Res. Clin. Oncol., 139, 223, 10.1007/s00432-012-1315-y Cuk, 2013, Plasma microRNA panel for minimally invasive detection of breast cancer, PLoS One, 8, e76729, 10.1371/journal.pone.0076729 Zearo, 2014, MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers, BMC Cancer, 14, 200, 10.1186/1471-2407-14-200 Mahn, 2011, Circulating microRNAs (miRNA) in serum of patients with prostate cancer, Urology, 77, 1265, 10.1016/j.urology.2011.01.020 Brase, 2011, Circulating miRNAs are correlated with tumor progression in prostate cancer, Int. J. Cancer, 128, 608, 10.1002/ijc.25376 Li, 2013, MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls, Clin. Cancer Res., 19, 3600, 10.1158/1078-0432.CCR-12-3092 Slesak, 2000, Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9, Cancer, 89, 83, 10.1002/1097-0142(20000701)89:1<83::AID-CNCR12>3.0.CO;2-J Bryant, 2012, Changes in circulating microRNA levels associated with prostate cancer, Br. J. Cancer, 106, 768, 10.1038/bjc.2011.595 Kawaguchi, 2013, Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer, Br. J. Cancer, 108, 361, 10.1038/bjc.2012.546 Nguyen, 2013, Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer, Prostate, 73, 346, 10.1002/pros.22572 Zhang, 2011, Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy, Prostate, 71, 326, 10.1002/pros.21246 Selth, 2013, Circulating microRNAs predict biochemical recurrence in prostate cancer patients, Br. J. Cancer, 109, 641, 10.1038/bjc.2013.369 Gonzales, 2011, Comparison of circulating microRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer, Clin. Genitourin Cancer, 9, 39, 10.1016/j.clgc.2011.05.008 Morimura, 2011, Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer, Br. J. Cancer, 105, 1733, 10.1038/bjc.2011.453 Cheng, 2013, Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia, PLoS One, 8, e69239, 10.1371/journal.pone.0069239 Ng, 2009, Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening, Gut, 58, 1375, 10.1136/gut.2008.167817 Faltejskova, 2012, Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: evidence against their usage as biomarkers in colorectal cancer, Cancer Biomark., 12, 199, 10.3233/CBM-130308 Huang, 2010, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer, Int. J. Cancer, 127, 118, 10.1002/ijc.25007 Wang, 2012, Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer, PLoS One, 7, e44398, 10.1371/journal.pone.0044398 Wang, 2014, Identification of a circulating microRNA signature for colorectal cancer detection, PLoS One, 9, e87451, 10.1371/journal.pone.0087451 Ogata-Kawata, 2014, Circulating exosomal microRNAs as biomarkers of colon cancer, PLoS One, 9, e92921, 10.1371/journal.pone.0092921 Toiyama, 2014, Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer, Ann. Surg., 259, 735, 10.1097/SLA.0b013e3182a6909d Cheng, 2011, Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis, PLoS One, 6, e17745, 10.1371/journal.pone.0017745 Brunet Vega, 2013, microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers, Oncol. Rep., 30, 320, 10.3892/or.2013.2475 Wang, 2012, Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis, Cancer Epidemiol., 36, e61, 10.1016/j.canep.2011.05.002 Zhang, 2014, Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy, Anticancer Drugs, 25, 346, 10.1097/CAD.0000000000000049 Kjersem, 2013, Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment, Mol. Oncol., 8, 59, 10.1016/j.molonc.2013.09.001 Yang, 2013, The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse, PLoS One, 8, e66842, 10.1371/journal.pone.0066842 Menendez, 2013, Prognostic implications of serum microRNA-21 in colorectal cancer, J. Surg. Oncol., 108, 369, 10.1002/jso.23415 Pu, 2010, Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression, J. Gastroenterol. Hepatol., 25, 1674, 10.1111/j.1440-1746.2010.06417.x Nugent, 2012, Circulating miR-34a levels are reduced in colorectal cancer, J. Surg. Oncol., 106, 947, 10.1002/jso.23174 Kanaan, 2012, Plasma miR-21: a potential diagnostic marker of colorectal cancer, Ann. Surg., 256, 544, 10.1097/SLA.0b013e318265bd6f Yong, 2013, Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer, BMC Cancer, 13, 280, 10.1186/1471-2407-13-280 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J. Clin., 55, 74, 10.3322/canjclin.55.2.74 Tsujiura, 2010, Circulating microRNAs in plasma of patients with gastric cancers, Br. J. Cancer, 102, 1174, 10.1038/sj.bjc.6605608 Zhou, 2010, Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker, J. Mol. Med. (Berl.), 88, 709, 10.1007/s00109-010-0617-2 Wang, 2012, Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer, Mol. Med. Rep., 5, 1514 Zheng, 2011, MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients, Cancer Biomark., 10, 71, 10.3233/CBM-2011-0231 Tsujiura, 2014, Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer, Gastric Cancer, 10.1007/s10120-014-0363-1 Komatsu, 2013, Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma, Anticancer Res., 33, 271 Kim, 2013, Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer, J. Mol. Diagn., 15, 661, 10.1016/j.jmoldx.2013.04.004 Valladares-Ayerbes, 2012, Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer, J. Transl. Med., 10, 186, 10.1186/1479-5876-10-186 Liu, 2012, Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer, Cancer Lett., 316, 196, 10.1016/j.canlet.2011.10.034 Li, 2013, MiRNA-199a-3p: a potential circulating diagnostic biomarker for early gastric cancer, J. Surg. Oncol., 108, 89, 10.1002/jso.23358 Zhu, 2014, A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer, Br. J. Cancer, 110, 2291, 10.1038/bjc.2014.119 Chen, 2014, Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer, Oncol. Rep., 31, 1863, 10.3892/or.2014.3004 Gorur, 2013, Determination of plasma microRNA for early detection of gastric cancer, Mol. Biol. Rep., 40, 2091, 10.1007/s11033-012-2267-7 Tsai, 2012, Aberrant expression of miR-196a in gastric cancers and correlation with recurrence, Gene Chromosome Cancer, 51, 394, 10.1002/gcc.21924 Zhang, 2012, The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma, Oncol. Res., 20, 139, 10.3727/096504012X13522227232156 Zhou, 2012, MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients, Biomarkers, 17, 104, 10.3109/1354750X.2011.614961 Zhu, 2014, A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer, Br. J. Cancer, 110, 2291, 10.1038/bjc.2014.119 Li, 2010, Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma, Cancer Res., 70, 9798, 10.1158/0008-5472.CAN-10-1001 Gui, 2011, Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies, Clin. Sci. (Lond.), 120, 183, 10.1042/CS20100297 Xu, 2011, Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis, Mol. Carcinog., 50, 136, 10.1002/mc.20712 Koberle, 2013, Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma, Eur. J. Cancer, 49, 3442, 10.1016/j.ejca.2013.06.002 Qi, 2011, Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection, PLoS One, 6, e28486, 10.1371/journal.pone.0028486 Qu, 2011, Circulating microRNAs as biomarkers for hepatocellular carcinoma, J. Clin. Gastroenterol., 45, 355, 10.1097/MCG.0b013e3181f18ac2 Tomimaru, 2012, Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma, J. Hepatol., 56, 167, 10.1016/j.jhep.2011.04.026 Liu, 2012, Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study, BMJ Open, 2, e000825, 10.1136/bmjopen-2012-000825 Borel, 2012, Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma, J. Hepatol., 56, 1371, 10.1016/j.jhep.2011.11.026 Abdalla, 2012, Promising candidate urinary microRNA biomarkers for the early detection of hepatocellular carcinoma among high-risk hepatitis C virus Egyptian patients, J. Cancer, 3, 19, 10.7150/jca.3.19 Li, 2011, Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance, Biochem. Biophys. Res. Commun., 406, 70, 10.1016/j.bbrc.2011.01.111 Li, 2012, Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening, Dig. Dis. Sci., 57, 2910, 10.1007/s10620-012-2317-y Giray, 2014, Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma, Mol. Biol. Rep., 41, 4513, 10.1007/s11033-014-3322-3 Shen, 2013, Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker, Cancer Epidemiol. Biomarkers Prev., 22, 2364, 10.1158/1055-9965.EPI-13-0237 Fu, 2013, Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma, Oncol. Lett., 6, 1811, 10.3892/ol.2013.1638 Chen, 2014, Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population, Eur. J. Haematol., 92, 407, 10.1111/ejh.12263 Moussay, 2011, MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia, Proc. Natl. Acad. Sci. U. S. A., 108, 6573, 10.1073/pnas.1019557108 Ferrajoli, 2013, Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia, Blood, 122, 1891, 10.1182/blood-2013-01-478222 Fayyad-Kazan, 2013, Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia, J. Transl. Med., 11, 31, 10.1186/1479-5876-11-31 Zhi, 2013, Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia, PLoS One, 8, e56718, 10.1371/journal.pone.0056718 Guo, 2010, Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma, Dis. Markers, 29, 251, 10.1155/2010/474692 Jones, 2014, Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma, Clin. Cancer Res., 20, 253, 10.1158/1078-0432.CCR-13-1024 Yang, 2013, Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas, Int. J. Cancer, 132, 116, 10.1002/ijc.27657 Komatsu, 2011, Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma, Br. J. Cancer, 105, 104, 10.1038/bjc.2011.198 Zheng, 2013, Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer, PLoS One, 8, e77853, 10.1371/journal.pone.0077853 Zhao, 2013, Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma, Exp. Mol. Pathol., 94, 115, 10.1016/j.yexmp.2012.10.005 Ouyang, 2013, A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma, Med. Oncol., 30, 340, 10.1007/s12032-012-0340-7 Yu, 2012, Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma, J. Clin. Endocrinol. Metab., 97, 2084, 10.1210/jc.2011-3059 Yu, 2012, Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion, J. Cancer Res. Clin. Oncol., 138, 671, 10.1007/s00432-012-1147-9 Carlsen, 2013, Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls, Pancreas, 42, 1107, 10.1097/MPA.0b013e318296bb34 Kishimoto, 2013, Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer, Cancer Sci., 104, 1626, 10.1111/cas.12300 Cheng, 2013, Plasma processing conditions substantially influence circulating microRNA biomarker levels, PLoS One, 8, e64795, 10.1371/journal.pone.0064795 Duttagupta, 2011, Impact of cellular miRNAs on circulating miRNA biomarker signatures, PLoS One, 6, e20769, 10.1371/journal.pone.0020769 Reid, 2011, Circulating microRNAs: association with disease and potential use as biomarkers, Crit. Rev. Oncol. Hematol., 80, 193, 10.1016/j.critrevonc.2010.11.004 McDonald, 2011, Analysis of circulating microRNA: preanalytical and analytical challenges, Clin. Chem., 57, 833, 10.1373/clinchem.2010.157198 Kroh, 2010, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, 50, 298, 10.1016/j.ymeth.2010.01.032 Shende, 2011, Expression and rhythmic modulation of circulating microRNAs targeting the clock gene Bmal1 in mice, PLoS One, 6, e22586, 10.1371/journal.pone.0022586 Kannan, 2009, Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis, Transfusion, 49, 1443, 10.1111/j.1537-2995.2009.02140.x Kannan, 2010, Differential profiling of human red blood cells during storage for 52 selected microRNAs, Transfusion, 50, 1581, 10.1111/j.1537-2995.2010.02585.x Moldovan, 2014, Methodological challenges in utilizing miRNAs as circulating biomarkers, J. Cell. Mol. Med., 18, 371, 10.1111/jcmm.12236 Page, 2013, Influence of plasma processing on recovery and analysis of circulating nucleic acids, PLoS One, 8, e77963, 10.1371/journal.pone.0077963 Wang, 2012, Comparing the microRNA spectrum between serum and plasma, PLoS One, 7, e41561, 10.1371/journal.pone.0041561 Osman, 2011, Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes, Platelets, 22, 433, 10.3109/09537104.2011.560305 Kirschner, 2011, Haemolysis during sample preparation alters microRNA content of plasma, PLoS One, 6, e24145, 10.1371/journal.pone.0024145 Song, 2012, Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients, Dig. Dis. Sci., 57, 897, 10.1007/s10620-011-1981-7 Benz, 2013, U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis, Exp. Mol. Med., 45, e42, 10.1038/emm.2013.81 Sanders, 2012, Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma, Int. J. Urol., 19, 1017, 10.1111/j.1442-2042.2012.03082.x Zheng, 2013, Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients, PLoS One, 8, e83025, 10.1371/journal.pone.0083025 Hu, 2014, Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients, Int. J. Cancer, 135, 1187, 10.1002/ijc.28757 Chen, 2013, A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs, PLoS One, 8, e79652, 10.1371/journal.pone.0079652 Ohshima, 2010, Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line, PLoS One, 5, e13247, 10.1371/journal.pone.0013247 Nelson, 2004, Microarray-based, high-throughput gene expression profiling of microRNAs, Nat. Methods, 1, 155, 10.1038/nmeth717 Cissell, 2008, Bioluminescence-based detection of microRNA, miR21 in breast cancer cells, Anal. Chem., 80, 2319, 10.1021/ac702577a Cheng, 2009, Highly sensitive determination of microRNA using target-primed and branched rolling-circle amplification, Angew. Chem. Int. Ed. Engl., 48, 3268, 10.1002/anie.200805665 Hong, 2013, Ultrasensitive electrochemical detection of cancer-associated circulating microRNA in serum samples based on DNA concatamers, Biosens. Bioelectron., 50, 132, 10.1016/j.bios.2013.06.040 Jia, 2010, Ultrasensitive detection of microRNAs by exponential isothermal amplification, Angew. Chem. Int. Ed. Engl., 49, 5498, 10.1002/anie.201001375 Van Ness, 2003, Isothermal reactions for the amplification of oligonucleotides, Proc. Natl. Acad. Sci. U. S. A., 100, 4504, 10.1073/pnas.0730811100 Ho, 2014, Self-assembling protein platform for direct quantification of circulating microRNAs in serum with total internal reflection fluorescence microscopy, Anal. Chim. Acta., 823, 61, 10.1016/j.aca.2014.03.020 Ren, 2013, A highly sensitive and selective electrochemical biosensor for direct detection of microRNAs in serum, Anal. Chem., 85, 4784, 10.1021/ac400583e Mori, 2009, Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases, J. Infect. Chemother., 15, 62, 10.1007/s10156-009-0669-9 Li, 2013, Isothermally sensitive detection of serum circulating miRNAs for lung cancer diagnosis, Anal. Chem., 85, 11174, 10.1021/ac403462f Katoh, 2009, Selective stabilization of mammalian microRNAs by 3′ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2, Genes Dev., 23, 433, 10.1101/gad.1761509 Jones, 2009, Zcchc11-dependent uridylation of microRNA directs cytokine expression, Nat. Cell Biol., 11, 1157, 10.1038/ncb1931 Muraoka, 2013, The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma, Lung Cancer, 82, 485, 10.1016/j.lungcan.2013.09.017 Liu, 2013, Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development, Protein Cell, 4, 932, 10.1007/s13238-013-3092-z Ohno, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Mol. Ther., 21, 185, 10.1038/mt.2012.180 Kosaka, 2013, Exosomal tumor-suppressive microRNAs as novel cancer therapy: “exocure” is another choice for cancer treatment, Adv. Drug Deliv. Rev., 65, 376, 10.1016/j.addr.2012.07.011 Koppers-Lalic, 2013, Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine, Adv. Drug Deliv. Rev., 65, 348, 10.1016/j.addr.2012.07.006 Fonsato, 2012, Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs, Stem Cells, 30, 1985, 10.1002/stem.1161 Katakowski, 2013, Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth, Cancer Lett., 335, 201, 10.1016/j.canlet.2013.02.019 Munoz, 2013, Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity, Mol. Ther. Nucleic Acids, 2, e126, 10.1038/mtna.2013.60